Clinical Application of Artificial Intelligence in Positron Emission Tomography: Imaging of Prostate Cancer.

Journal: PET clinics
Published Date: Jan 1, 2022

Abstract

PET imaging with targeted novel tracers has been commonly used in the clinical management of prostate cancer. The use of artificial intelligence (AI) in PET imaging is a relatively new approach and in this review article, we will review the current trends and categorize the currently available research into the quantification of tumor burden within the organ, evaluation of metastatic disease, and translational/supplemental research which aims to improve other AI research efforts.

Authors

  • Kevin Ma
    Artificial Intelligence Resource, Molecular Imaging Branch, NCI, NIH, Bethesda, MD, USA.
  • Stephanie A Harmon
    Clinical Research Directorate, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, Maryland, USA.
  • Ivan S Klyuzhin
    Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Arman Rahmim
  • Baris Turkbey
    Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Keywords

External Resources

Popular Topics
Recent Journals